April 8, 2016 — Mach7 Technologies and 3D Medical announced the completion of their merger. The combined company will bring advanced medical image management solutions to customers across five continents. Mach7 Technologies Limited begins trading on the Australian Stock Exchange under the symbol M7T.
Mach7 is a global provider of enterprise image management systems that are used at hundreds of healthcare sites. 3D Medical offers medical 3-D printing technologies and solutions that deliver a new level of medical certainty for both health professionals and patients. 3D Medical is now a wholly-owned subsidiary of Mach7 Technologies.
The merger provides Mach7 access to international capital markets while preserving corporate self-determination for both entities in both mission and product roadmap. Mach7 and 3D Medical intend to maintain their respective workforces in engineering, customer sales, support, marketing and service relationships. Mach7 will maintain its Burlington, Vt., headquarters for product development, professional services, sales and marketing, with expanded sales throughout Australia, New Zealand and Western Europe.
Shareholders of 3D Medical and Mach7 Technologies approved the merger on March 31, 2016, including the name change to Mach7 Technologies Limited. Albert Liong was appointed managing director and CEO, Jenni Pilcher becomes the global CFO and CEO of Australia operations, and Ken Poutakidis was appointed non-executive chairman.
For more information: www.mach7t.com
March 10, 2026 
